Stocks · News reference

Organon Announces Enrollment Now Open For MIUDELLA REMS Certification Program Ahead Of Copper IUD's US Launch In Late 2026

Aug 11, 2026, 11:32 AMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaOct 16, 2026, 11:34 AMBenzinga Newsdesk
Organon To Present Data From Its Current Phase 3 Trial Of MIUDELLA Intrauterine Device At 2026 Society Of Family Planning Annual Meeting
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced that Sebela Women’s Health will present interim results from an
OGN
BenzingaSep 28, 2026, 12:09 PMBenzinga Newsdesk
Organon Canada Announces Availability Of NDUVRA To Treat Moderate To Severe Atopic Dermatitis
Organon Canada, a global healthcare company, today announces the approval and availability of NDUVRA® (tapinarof cream), 1%, for the topical treatment of moderate to severe atopic dermatitis in adult and pediatric
OGN
BenzingaSep 14, 2026, 11:35 AMBenzinga Newsdesk
Organon Says FDA Accepted For Review Sebela's sNDA To Extend MIUDELLA Copper IUD Duration Of Use From 3 To 6 Years; PDUFA Action Expected In Q2 2027
OGN
BenzingaAug 13, 2026, 3:01 PMBenzinga Insights
This House of Representative Just Sold Up To $30K In Organon Stock
A report on August 12, 2026 shows that Representative Kevin Hern from Oklahoma sale stock in Organon (NYSE:OGN), valued between $2,002 and $30,000. According to the August filing, the transaction occurred on August 5,
EL OGN XOM